Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    IntriCon Corporation (IIN)

    Price:

    24.23 USD

    ( + 0.03 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    IIN
    Name
    IntriCon Corporation
    Industry
    Medical - Instruments & Supplies
    Sector
    Healthcare
    Price
    24.230
    Market Cap
    0
    Enterprise value
    146.514M
    Currency
    USD
    Ceo
    Mark Gorder
    Full Time Employees
    873
    Ipo Date
    1980-03-17
    City
    Arden Hills
    Address
    1260 Red Fox Road

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Atrion Corporation

    VALUE SCORE:

    0

    Symbol
    ATRI
    Market Cap
    809.436M
    Industry
    Medical - Instruments & Supplies
    Sector
    Healthcare

    2nd position

    DENTSPLY SIRONA Inc.

    VALUE SCORE:

    9

    Symbol
    XRAY
    Market Cap
    2.470B
    Industry
    Medical - Instruments & Supplies
    Sector
    Healthcare

    The best

    Pro-Dex, Inc.

    VALUE SCORE:

    10

    Symbol
    PDEX
    Market Cap
    113.305M
    Industry
    Medical - Instruments & Supplies
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    -3.438k
    P/S
    0
    P/B
    2.350
    Debt/Equity
    0.056
    EV/FCF
    0.166
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    -0.003
    Earnings yield
    -0.000
    Debt/assets
    0.043
    FUNDAMENTALS
    Net debt/ebidta
    -0.061
    Interest coverage
    2.381
    Research And Developement To Revenue
    0.042
    Intangile to total assets
    0.187
    Capex to operating cash flow
    5.717
    Capex to revenue
    0.020
    Capex to depreciation
    0.452
    Return on tangible assets
    -0.001
    Debt to market cap
    Piotroski Score
    FUNDAMENTALS
    PEG
    -34.384
    P/CF
    502.413
    P/FCF
    0
    RoA %
    -0.052
    RoIC %
    -0.043
    Gross Profit Margin %
    25.067
    Quick Ratio
    2.470
    Current Ratio
    3.680
    Net Profit Margin %
    -0.051
    Net-Net
    2.566
    FUNDAMENTALS PER SHARE
    FCF per share
    -0.227
    Revenue per share
    13.786
    Net income per share
    -0.007
    Operating cash flow per share
    0.048
    Free cash flow per share
    -0.227
    Cash per share
    2.753
    Book value per share
    10.323
    Tangible book value per share
    7.804
    Shareholders equity per share
    10.312
    Interest debt per share
    0.579
    TECHNICAL
    52 weeks high
    24.930
    52 weeks low
    12.470
    Current trading session High
    24.230
    Current trading session Low
    24.210
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    DESCRIPTION

    IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. It offers micro-miniature products, microelectronics, micro-mechanical assemblies, high-precision injection-molded plastic components, and assemblies and software solutions for medical devices, hearing healthcare, and professional audio communication devices markets. The company also provides micro coils for surgical navigation clinical applications, such as interventional pulmonology and electrophysiology; joint engineering and manufacturing services for complex medical devices, including catheters covering a range of applications for cardiology, peripheral vascular, neurology, radiology, and pulmonology; bubble sensors and flow restrictors that monitor and control the flow of fluid in an intravenous infusion system; and safety needle products for original equipment manufacturing customers. In addition, it offers professional audio headset products used for emergency response needs in the fire, law enforcement, safety, aviation, and military markets; and a line of miniature ear- and head-worn devices used by performers and support staff in the music and stage performance markets. The company sells its hearing device products, and medical and professional audio communications products directly to hearing instrument manufacturers, distributors, and partnerships; and microphone products to the radio communication and professional audio industries, as well as markets and sells hearing aid devices directly to consumers through direct mail advertising, Internet, and call center. The company was formerly known as Selas Corporation of America and changed its name to IntriCon Corporation. The company was incorporated in 1930 and is headquartered in Arden Hills, Minnesota.

    NEWS
    https://images.financialmodelingprep.com/news/intricon-announces-completion-of-acquisition-by-an-affiliate-of-20220524.jpg
    Intricon Announces Completion of Acquisition by an Affiliate of Altaris Capital Partners

    globenewswire.com

    2022-05-24 16:05:00

    Investment by Altaris Supports Intricon's Ability to Deliver Innovative Solutions and Service to its Customers Investment by Altaris Supports Intricon's Ability to Deliver Innovative Solutions and Service to its Customers

    https://images.financialmodelingprep.com/news/shareholder-investigation-halper-sadeh-llp-investigates-obnk-iin-y-20220426.jpg
    SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates OBNK, IIN, Y, VEC

    prnewswire.com

    2022-04-26 09:00:00

    NEW YORK , April 26, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Origin Bancorp, Inc. (NASDAQ: OBNK)'s merger with BT Holdings, Inc. (BTH). Under the terms of the agreement, BTH shareholders will receive an aggregate of 6,828,390 shares of Origin's common stock in exchange for all outstanding shares of BTH common stock, subject to certain adjustments.

    https://images.financialmodelingprep.com/news/ttdky-vs-iin-which-stock-should-value-investors-buy-20220328.jpeg
    TTDKY vs. IIN: Which Stock Should Value Investors Buy Now?

    zacks.com

    2022-03-28 12:48:11

    TTDKY vs. IIN: Which Stock Is the Better Value Option?

    https://images.financialmodelingprep.com/news/intricon-investor-alert-by-the-former-attorney-general-of-20220303.jpg
    INTRICON INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intricon Corporation - IIN

    businesswire.com

    2022-03-03 21:06:00

    NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Intricon Corporation (NasdaqGM: IIN) to an affiliate of Altaris Capital Partners, LLC. Under the terms of the proposed transaction, shareholders of Intricon will receive only $24.25 in cash for each share of Intricon that they own. KSF is seeking to determine whether this consideration and the process that led

    https://images.financialmodelingprep.com/news/intricon-investor-alert-by-the-former-attorney-general-of-louisiana-20220303.jpg
    INTRICON INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intricon Corporation - IIN

    businesswire.com

    2022-03-03 21:06:00

    NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Intricon Corporation (NasdaqGM: IIN) to an affiliate of Altaris Capital Partners, LLC. Under the terms of the proposed transaction, shareholders of Intricon will receive only $24.25 in cash for each share of Intricon that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company. If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqgm-iin/ to learn more. To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.

    https://images.financialmodelingprep.com/news/stocks-to-invest-in-right-now-5-health-care-20220301.jpg
    Stocks To Invest In Right Now? 5 Health Care Stocks For Your March Watchlist

    stockmarket.com

    2022-03-01 21:12:02

    Do these healthcare stocks pique your interest?

    https://images.financialmodelingprep.com/news/intricon-corporation-iin-stock-why-it-surged-today-20220228.jpeg
    IntriCon Corporation (IIN) Stock: Why It Surged Today

    pulse2.com

    2022-02-28 22:17:24

    The IntriCon Corporation (NASDAQ: IIN) stock increased by 37.37% today. This is why.

    https://images.financialmodelingprep.com/news/shareholder-alert-weisslaw-llp-investigates-intricon-corporation-20220228.jpg
    SHAREHOLDER ALERT: WeissLaw LLP Investigates IntriCon Corporation

    prnewswire.com

    2022-02-28 16:30:00

    NEW YORK , Feb. 28, 2022 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of IntriCon Corporation ("IntriCon" or the "Company") (NASDAQ: IIN), in connection with the proposed acquisition of the Company by an affiliate of Altaris Capital Partners, LLC ("Altaris").  Under the terms of the merger agreement, the Company's shareholders will receive $24.25 in cash for each share of IntriCon common stock that they hold.

    https://images.financialmodelingprep.com/news/shareholder-alert-rigrodsky-law-pa-announces-investigation-of-intricon-20220228.jpg
    SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Intricon Corporation Buyout

    newsfilecorp.com

    2022-02-28 13:33:00

    Wilmington, Delaware--(Newsfile Corp. - February 28, 2022) - Rigrodsky Law, P.A. announces that it is investigating Intricon Corporation ("Intricon") (NASDAQ: IIN) regarding possible breaches of fiduciary duties and other violations of law related to Intricon's agreement to be acquired by an affiliate of Altaris Capital Partners. Under the terms of the agreement, Intricon's shareholders will receive $24.25 in cash for each share of Intricon common stock they own.To learn more about this investigation and your...

    https://images.financialmodelingprep.com/news/why-are-intricon-shares-surging-monday-20220228.jpg
    Why Are Intricon Shares Surging Monday

    benzinga.com

    2022-02-28 13:20:00

    Altaris Capital Partners LLC will acquire Implantable device maker Intricon Corporation (NASDAQ: IIN) for $24.25 per share in a transaction that values Intricon at an equity value of approximately $241 million.  The purchase price represents a premium of approximately 39%.

    https://images.financialmodelingprep.com/news/shareholder-alert-ademi-llp-investigates-whether-intricon-corporation-has-20220228.jpg
    Shareholder Alert: Ademi LLP investigates whether Intricon Corporation has obtained a Fair Price in its transaction with Altaris.

    prnewswire.com

    2022-02-28 11:58:00

    MILWAUKEE, Feb. 28, 2022 /PRNewswire/ -- Ademi LLP is investigating Intricon (NASDAQ: IIN) for possible breaches of fiduciary duty and other violations of law in its transaction with Altaris.  Click here to learn how to join the action: https://www.ademilaw.com/case/intricon-corporation or call Guri Ademi toll-free at 866-264-3995.

    https://images.financialmodelingprep.com/news/iin-stock-alert-halper-sadeh-llp-is-investigating-whether-20220228.jpg
    IIN Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of IntriCon Corporation Is Fair to Shareholders

    businesswire.com

    2022-02-28 11:52:00

    NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, an investor rights law firm, is investigating whether the sale of IntriCon Corporation (NASDAQ: IIN) to an affiliate of Altaris Capital Partners, LLC for $24.25 per share is fair to IntriCon shareholders. Halper Sadeh encourages IntriCon shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns whether IntriCon and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for IntriCon shareholders; (2) determine whether Altaris is underpaying for IntriCon; and (3) disclose all material information necessary for IntriCon shareholders to adequately assess and value the merger consideration. On behalf of IntriCon shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits. Halper Sadeh encourages IntriCon shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. Attorney Advertising. Prior results do not guarantee a similar outcome.

    https://images.financialmodelingprep.com/news/iin-stock-alert-halper-sadeh-llp-is-investigating-whether-the-20220228.jpg
    IIN Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of IntriCon Corporation Is Fair to Shareholders

    businesswire.com

    2022-02-28 11:52:00

    NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, an investor rights law firm, is investigating whether the sale of IntriCon Corporation (NASDAQ: IIN) to an affiliate of Altaris Capital Partners, LLC for $24.25 per share is fair to IntriCon shareholders. Halper Sadeh encourages IntriCon shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concern

    https://images.financialmodelingprep.com/news/intricon-reports-fourth-quarter-and-full-year-2021-results-20220228.jpg
    Intricon Reports Fourth Quarter and Full Year 2021 Results

    globenewswire.com

    2022-02-28 08:40:00

    ARDEN HILLS, Minn., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, today announced financial results for its fourth quarter and year ended December 31, 2021.

    https://images.financialmodelingprep.com/news/intricon-enters-into-agreement-to-be-acquired-by-an-20220228.jpg
    Intricon Enters into Agreement to be Acquired by an Affiliate of Altaris Capital Partners for $241 Million

    globenewswire.com

    2022-02-28 08:35:00

    Intricon Shareholders to Receive $24.25 Per Share in Cash Intricon Shareholders to Receive $24.25 Per Share in Cash

    https://images.financialmodelingprep.com/news/ttdky-vs-iin-which-stock-is-the-better-value-20220223.jpg
    TTDKY vs. IIN: Which Stock Is the Better Value Option?

    zacks.com

    2022-02-23 13:06:22

    TTDKY vs. IIN: Which Stock Is the Better Value Option?